Sustained Mechanical Release of Dexamethasone Sodium Phosphate from a Foldable Capsular Vitreous Body
Authors:
Open Access
- 1 March 2010
- journal article
- retina
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 51 (3) , 1636-1642
Abstract
Purpose.: Since 300-nm-mili apertures were present in the capsule of the foldable capsular vitreous body (FCVB), the authors tested whether the FCVB could mechanically release dexamethasone sodium phosphate (DexP) from its capsule. Methods.: In the in vitro study, DexP at concentrations of 0.25, 0.5, 1, 2, and 4 mg/mL in a balanced salt solution were injected into the capsules, which were immersed in cups of modified Franz diffusion cells. Two hundred microliters of liquid was aspirated at time intervals of 10, 20, 40, 60, 120, 180, 240, 300, and 360 minutes. In the in vivo study, the capsule was folded and implanted into the vitreous cavities of five rabbits. Approximately 0.6 mL DexP (2 mg/mL) was then injected into the capsule. An intravitreal injection with DexP was performed on another five rabbits as the control group. Aqueous humor was aspirated on days 1, 3, 7, 14, 28, and 42 after implantation. The DexP contents in the cups and aqueous humor were detected by HPLC-MS/MS. Results.: FCVB released DexP in a time-dependent and dose-dependent manner in vitro with five dosages from 10 to 360 minutes. Especially in the 0.25 mg/mL DexP group, the content (y) had good linear relationships with time (x), as shown by y = 0.7635x + 10.205. The DexP contents in the aqueous humor were detected until day 28 and were undetectable on day 42. However, the DexP contents were detected only before day 3 in the controls. Conclusions.: FCVB can sustainably and mechanically release DexP by capsule apertures in a time-dependent and dose-dependent manner in addition to serving as a vitreous substitute.Keywords
This publication has 18 references indexed in Scilit:
- Refractive Shifts in Four Selected Artificial Vitreous Substitutes Based on Gullstrand-Emsley and Liou-Brennan Schematic EyesInvestigative Ophthalmology & Visual Science, 2009
- INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTSRetina, 2009
- Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injectionEye, 2009
- Iluvien™: a new sustained delivery technology for posterior eye diseaseExpert Opinion on Drug Delivery, 2008
- A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valveEye, 2007
- In Vivo Retinal Tolerance of Various Heavy Silicone OilsInvestigative Ophthalmology & Visual Science, 2007
- Pharmacokinetic and Toxicity Investigations of a New Intraocular Lens with a Dexamethasone Drug Delivery System: A Pilot StudyOphthalmologica, 2006
- Drug delivery systems for vitreoretinal diseasesProgress in Retinal and Eye Research, 2004
- Safety and efficacy of a dexamethasone anterior segment drug delivery system in patients after phacoemulsificationJournal of Cataract & Refractive Surgery, 2004
- Silicone oil in the repair of complex retinal detachmentsOphthalmology, 1998